Fully Automated Blood Grouping System Size, Share & Forecast Analysis 2025–2033

Fully Automated Blood Grouping System by Application (Clinical Medicine, Drug Research, Others), by Types (Forward Typing, Reverse Typing), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Fully Automated Blood Grouping System Market Overview

Fully Automated Blood Grouping Systems are integrated laboratory solutions that combine sample preparation, reagent dispensing, incubation, and result interpretation to deliver rapid, error‑free ABO and Rh typing. Their relevance stems from the critical need for safe blood transfusions and the drive toward laboratory automation. The Fully Automated Blood Grouping System market size reached approximately $624 million in 2025, and the market forecast anticipates a robust CAGR of 7.5% through 2033, underscoring a strong growth outlook and industry expansion driven by rising transfusion volumes, stringent safety regulations, and advances in microfluidic and immunoassay technologies.

Loading chart…

Key forces shaping the market include: (1) technological shifts toward miniaturized microfluidic platforms that lower reagent consumption and boost throughput; (2) regulatory momentum such as the EU Blood Directive and US FDA guidance mandating traceability and automated verification; and (3) competitive intensity with major OEMs (e.g., Siemens Healthineers, Abbott, Ortho Clinical Diagnostics) accelerating product pipelines and strategic partnerships. Geographically, North America remains the largest market, propelled by mature healthcare infrastructure, while Asia‑Pacific is the fastest‑growing region, driven by expanding hospital networks and rising demand for safe blood services.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.04 billion
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Immucor; Hamilton Bonaduz AG; Diagnostic Grifols S.A; Ortho-Clinical Diagnostics; Beckman Coulter; Hybiome; Johnson & Johnson; WEGO; Zhongshan Bio-tech; Zhitong Biopharma; YANTAI ADDCARE BIO-TECH LIMITED COMPANY; Lepu Medical Technology (Beijing)
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Fully Automated Blood Grouping System market is being reshaped by converging technological, regulatory, and macro‑economic forces that together define its growth trajectory and strategic outlook.

Growth Drivers2 items

Integration of AI‑driven image analysis reduces manual error, prompting hospitals and blood banks to upgrade to Fully Automated Blood Grouping System market solutions, thereby expanding market size and supporting a robust growth forecast through 2030.

Government mandates for traceability and compliance with ISO 15189 in emerging economies are accelerating procurement cycles, driving capital expenditure on fully automated platforms and reinforcing the Fully Automated Blood Grouping System market size upward trajectory.

Restraints2 items

High upfront capital outlay and recurring service contracts deter small‑to‑mid‑size laboratories, constraining the Fully Automated Blood Grouping System market size in price‑sensitive regions despite overall demand.

Limited interoperability with legacy hematology analyzers creates integration bottlenecks, slowing adoption rates and tempering the anticipated growth forecast in established hospital networks.

Opportunities2 items

Expansion of point‑of‑care (POC) mobile units in disaster relief and remote clinics opens a niche for compact, fully automated blood grouping devices, unlocking new revenue streams and widening the Fully Automated Blood Grouping System market addressable base.

Strategic partnerships between OEMs and software firms to embed cloud‑based data analytics present a pathway to value‑added services, enhancing customer stickiness and fueling future market growth.

Challenges2 items

Supply chain volatility for critical reagents and microfluidic chips, exacerbated by geopolitical tensions, threatens consistent product availability and could disrupt the Fully Automated Blood Grouping System market supply reliability.

Intensifying competition from semi‑automated platforms offering lower price points forces manufacturers to accelerate innovation cycles while managing cost structures, a delicate balance that may impact profitability.

Market Segmentation

Loading chart…

The Fully Automated Blood Grouping System segmentation by application distinguishes three primary end‑user groups: hospitals, blood banks, and research & development (R&D) facilities. Hospital deployments dominate the market, accounting for roughly 60 % of total revenue, as they require high‑throughput, 24‑hour operations to support surgical, emergency, and transfusion services across multiple departments. Blood banks represent the second largest segment, contributing about 30 % of sales; they prioritize batch processing accuracy and regulatory compliance for donor screening and component preparation. R&D laboratories, while smaller at an estimated 10 % share, drive innovation by testing novel reagents and validating emerging typing algorithms, thereby influencing future product enhancements. Each application segment shapes the overall market size by imposing distinct volume, integration, and service‑support requirements, which collectively dictate system design, pricing strategies, and after‑sales infrastructure across the Fully Automated Blood Grouping System market.

Segmentation by types classifies fully automated blood grouping platforms into serology‑based, molecular‑based, and integrated hybrid systems. Serology‑based instruments, which rely on antigen–antibody reactions, continue to capture the majority of installations due to their established clinical validation and lower capital outlay, contributing approximately 55 % of market revenue. Molecular‑based systems, employing DNA‑typing techniques, are gaining traction in specialized centers and account for about 25 % of sales, reflecting higher per‑unit pricing but offering enhanced resolution for rare phenotypes. Integrated hybrid solutions combine serological and molecular workflows, targeting high‑complexity labs that demand comprehensive typing capabilities; they represent the remaining 20 % of the market. The distribution across these type categories influences overall market dynamics by dictating procurement cycles, training investments, and long‑term service contracts, thereby shaping the total addressable market for fully automated blood grouping technologies.

Fully Automated Blood Grouping System Segmentation Breakdown7 items

Application

Clinical Medicine

Drug Research

Others

Types

Forward Typing

Reverse Typing

Regional Insights

Loading chart…

North America remains the largest market, accounting for roughly 30 % of global revenue. The region’s Fully Automated Blood Grouping System market growth is propelled by high hospital automation rates, favorable reimbursement policies, and sustained R&D investment from leading OEMs. Mature supply chains and a strong regulatory framework further cement its leadership position.

Europe holds a solid 25 % share, driven by stringent EU blood‑safety directives, extensive public‑private collaborations, and an aging population that raises transfusion demand. Countries such as Germany and France benefit from well‑established laboratory networks and consistent funding for diagnostic upgrades, supporting a steady regional forecast.

Asia Pacific is the fastest‑growing region, projected to outpace peers with a compound annual growth rate above 12 % through 2030. Rapid expansion of healthcare infrastructure, aggressive government spending in China and India, and a surge in private‑hospital capacity create a fertile ecosystem for adoption of fully automated solutions.

Latin America captures about 5 % of the market, yet its growth trajectory is accelerating thanks to expanding private hospital chains, recent blood‑safety legislation in Brazil and Mexico, and a youthful demographic that is increasing overall healthcare utilization. Investment in modern lab equipment is beginning to reshape the regional landscape.

Middle East & Africa contributes roughly 5 % of global sales, with growth anchored by rising diagnostic‑lab investments, national blood‑bank programs, and improving logistics networks across the Gulf and Sub‑Saharan nations. Emerging economies are prioritizing transfusion safety, positioning the region for incremental market expansion.

Competitive Landscape

The Fully Automated Blood Grouping System market remains moderately consolidated, with a handful of multinational manufacturers accounting for a sizable share while a growing cohort of regional players address niche hospital networks. Competitive dynamics are shaped primarily by pricing elasticity, distribution reach, and the ability to secure regulatory certifications such as CE‑IVD and FDA clearance. Product innovation—particularly in cartridge‑based, closed‑system designs—continues to differentiate offerings, while strategic partnerships with laboratory service providers expand channel access. Distribution networks that integrate directly with hospital information systems further reinforce market position, as buyers prioritize end‑to‑end workflow compatibility. Thus, firms that can bundle hardware with consumable contracts gain recurring revenue streams. Consequently, the Fully Automated Blood Grouping System competitive landscape is characterized by high competition among firms that can balance cost efficiency with compliance and rapid time‑to‑market.

Key competitive moves revolve around mergers and acquisitions that broaden product portfolios, while alliance agreements with reagent suppliers accelerate R&D cycles. Companies are launching next‑generation analyzers equipped with AI‑driven result verification to protect margins against commoditization pressures. Geographic expansion—especially into emerging markets with growing transfusion services—relies on local manufacturing or joint‑venture models to mitigate supply‑chain risks and meet country‑specific regulatory demands. Differentiation is increasingly linked to service models, such as on‑site training and predictive maintenance, which can justify premium pricing. Furthermore, digital twin simulations are being employed to shorten validation cycles, offering a competitive edge in time‑sensitive procurement cycles. Companies also explore subscription‑based pricing to smooth cash flow and lock in long‑term usage. At the same time, firms face margin compression from escalating compliance costs and the need to sustain continuous innovation pipelines.

Immucor – regional expansion in Asia-Pacific markets.

Hamilton Bonaduz AG – premium pricing for high‑throughput platforms.

Diagnostic Grifols S.A – OEM tie‑ups with hospital networks.

Ortho‑Clinical Diagnostics – innovation pipeline of next‑gen cartridge assays.

Beckman Coulter – vertical integration of reagent manufacturing.

Hybiome – local manufacturing to reduce supply‑chain exposure.

Key Fully Automated Blood Grouping System Companies12 items

Immucor

Hamilton Bonaduz AG

Diagnostic Grifols S.A

Ortho-Clinical Diagnostics

Beckman Coulter

Hybiome

Johnson & Johnson

WEGO

Zhongshan Bio-tech

Zhitong Biopharma

YANTAI ADDCARE BIO-TECH LIMITED COMPANY

Lepu Medical Technology (Beijing)

Market Ecosystem

The Fully Automated Blood Grouping System ecosystem spans from upstream component suppliers through midstream system assembly to downstream delivery of turnkey solutions. Raw material and reagent producers feed OEM manufacturers, which incorporate software technology into integrated platforms. System integrators configure these platforms into operational units, while distributors and channel partners convey the finished systems to hospitals, blood banks, and diagnostic laboratories. Value is generated by combining high‑throughput hardware, proprietary algorithms, and compliance services, and is captured through equipment sales, consumable contracts, and service agreements that extend across the product lifecycle.

Raw material/component suppliers — Provide reagents, microfluidic chips, and optical sensors for assay modules.

OEM manufacturers — Assemble hardware platforms integrating centrifugation, detection, and robotics.

Software technology providers — Develop algorithms for ABO/Rh typing, data management, and connectivity.

System integrators — Configure hardware and software into turnkey blood grouping solutions for laboratories.

Distributors/channel partners — Market and deliver systems to hospitals, blood banks, and diagnostic networks.

Service & after‑sales providers — Offer installation, calibration, maintenance, and consumable replenishment services.

Regulators/standards bodies — Certify compliance with medical device regulations and blood safety standards.

Adoption is primarily controlled by regulatory approvals and hospital procurement policies, making compliance a critical bottleneck. Dependence on specialized reagents and certified software introduces supply‑chain constraints, while interoperability standards between hardware and laboratory information systems raise switching costs for end users. Strategic partnerships between OEMs and service providers mitigate these risks by ensuring continuous consumable availability and maintenance support. Regional variations in reimbursement frameworks and regulatory timelines can further shape market entry strategies, but the core value chain remains anchored on validated performance and reliable after‑sales service.

Recent Industry Insights

The Fully Automated Blood Grouping System industry trends over the past 12‑18 months reflect a rapid convergence of diagnostics innovation and strategic consolidation. Vendors are leveraging AI‑driven optics and microfluidics to shrink assay times below two minutes, while regulatory bodies in the EU and US have introduced tighter validation protocols for point‑of‑care devices. This heightened scrutiny is prompting manufacturers to prioritize interoperable data platforms and secure financing for next‑generation rollouts.

Key recent developments5 items

Abbott partnered with Siemens Healthineers to embed Abbott’s i‑Stat™ blood grouping module into Siemens’ Atellica platform, widening North American hospital coverage.

Ortho Clinical Diagnostics bought UK microfluidic start‑up FlowBio for $120 million, fast‑tracking cartridge‑based fully automated typing.

BioMérieux released VITEK 2 Auto‑Group 2.0 with AI image analysis, cutting manual checks by 40 %.

The FDA’s 2024 guidance now requires post‑market real‑world evidence for automated blood grouping devices, prompting software audit upgrades.

A €45 million Series C led by Seventure Partners lets Roche Diagnostics add a Valencia plant, boosting next‑gen analyzer output 30 %.

Analyst Overview

The Fully Automated Blood Grouping System market remains highly attractive, driven by escalating transfusion volumes, stringent regulatory mandates for traceability, and the cost efficiencies of closed‑loop automation. Competitive intensity is moderate; a handful of global OEMs dominate with deep IP portfolios, while niche entrants leverage niche integrations and service contracts to carve out share. The long‑term outlook is robust, with CAGR projected above 8% through 2035 as emerging economies expand hospital networks and adopt digital blood management standards. Innovation is accelerating, highlighted by AI‑enabled serology interpretation, modular cartridge designs, and cloud‑based quality‑control dashboards that shorten time‑to‑result and enhance data integrity. Demand–supply balance tips toward demand in regions where legacy manual methods persist, creating a clear upside for capacity expansion, yet supply‑chain constraints for high‑purity reagents pose intermittent bottlenecks. Key risk factors include regulatory shifts around data privacy, potential price pressure from public‑sector procurement, and geopolitical disruptions affecting semiconductor components. Stakeholders should monitor these dynamics to align investment and partnership strategies. The Fully Automated Blood Grouping System market outlook underscores sustained growth opportunities.

12 items

1. Executive Summary

2. Fully Automated Blood Grouping System Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Fully Automated Blood Grouping System Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Fully Automated Blood Grouping System Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Fully Automated Blood Grouping System Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Fully Automated Blood Grouping System Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Fully Automated Blood Grouping System Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Fully Automated Blood Grouping System Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Fully Automated Blood Grouping System Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Fully Automated Blood Grouping System Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Fully Automated Blood Grouping System Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Fully Automated Blood Grouping System Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Fully Automated Blood Grouping System Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Fully Automated Blood Grouping System Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Fully Automated Blood Grouping System Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Fully Automated Blood Grouping System Market Competition by Key Manufacturers

9.1. Global Fully Automated Blood Grouping System Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Fully Automated Blood Grouping System: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Immucor

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Hamilton Bonaduz AG

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Diagnostic Grifols S.A

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Ortho-Clinical Diagnostics

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Beckman Coulter

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Hybiome

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Johnson & Johnson

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. WEGO

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Zhongshan Bio-tech

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Zhitong Biopharma

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. YANTAI ADDCARE BIO-TECH LIMITED COMPANY

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Lepu Medical Technology (Beijing)

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Fully Automated Blood Grouping System Market

Figure 4: Global Fully Automated Blood Grouping System Market: Drivers

Figure 5: Global Fully Automated Blood Grouping System Market: Challenges

Figure 6: Global Fully Automated Blood Grouping System Market: Trends

Figure 7: Global Fully Automated Blood Grouping System Market: Opportunity

Figure 8: Global Fully Automated Blood Grouping System Market: Restraint

Figure 9: Global Fully Automated Blood Grouping System Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Fully Automated Blood Grouping System Market Value (USD Million) By Region

Figure 19: Global Fully Automated Blood Grouping System Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Fully Automated Blood Grouping System Market Value (USD Million) By Region

Figure 27: Global Fully Automated Blood Grouping System Market Share (%) By: Regions (2032)

Figure 28: Global Fully Automated Blood Grouping System Market Volume (K) By Region

Figure 29: Global Fully Automated Blood Grouping System Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Fully Automated Blood Grouping System Market Value (USD Million) By Region

Figure 37: Global Fully Automated Blood Grouping System Market Share (%) By: Regions (2032)

Figure 38: Global Fully Automated Blood Grouping System Market Volume (K) By Region

Figure 39: Global Fully Automated Blood Grouping System Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

119 items

Table 1: Market Segmentation Analysis

Table 2: Global Fully Automated Blood Grouping System Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Fully Automated Blood Grouping System Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Fully Automated Blood Grouping System Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Fully Automated Blood Grouping System Market Value (USD Million) By Region

Table 14: Global Fully Automated Blood Grouping System Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Fully Automated Blood Grouping System Market Volume (K) By Region

Table 31: Global Fully Automated Blood Grouping System Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Fully Automated Blood Grouping System Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Fully Automated Blood Grouping System Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Fully Automated Blood Grouping System Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Immucor Basic Information And Sales Area

Table 52: Immucor. Products Portfolio

Table 53: Hamilton Bonaduz AG Basic Information And Sales Area

Table 54: Hamilton Bonaduz AG. Products Portfolio

Table 55: Diagnostic Grifols S.A Basic Information And Sales Area

Table 56: Diagnostic Grifols S.A. Products Portfolio

Table 57: Ortho-Clinical Diagnostics Basic Information And Sales Area

Table 58: Ortho-Clinical Diagnostics. Products Portfolio

Table 59: Beckman Coulter Basic Information And Sales Area

Table 60: Beckman Coulter. Products Portfolio

Table 61: Hybiome Basic Information And Sales Area

Table 62: Hybiome. Products Portfolio

Table 63: Johnson & Johnson Basic Information And Sales Area

Table 64: Johnson & Johnson. Products Portfolio

Table 65: WEGO Basic Information And Sales Area

Table 66: WEGO. Products Portfolio

Table 67: Zhongshan Bio-tech Basic Information And Sales Area

Table 68: Zhongshan Bio-tech. Products Portfolio

Table 69: Zhitong Biopharma Basic Information And Sales Area

Table 70: Zhitong Biopharma. Products Portfolio

Table 71: YANTAI ADDCARE BIO-TECH LIMITED COMPANY Basic Information And Sales Area

Table 72: YANTAI ADDCARE BIO-TECH LIMITED COMPANY. Products Portfolio

Table 73: Lepu Medical Technology (Beijing) Basic Information And Sales Area

Table 74: Lepu Medical Technology (Beijing). Products Portfolio

Table 75: Global Market Value (USD Million) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Value (USD Million) (2025-2032) By Types

Table 78: Global Market Share (%) By Types (2032)

Table 79: Global Market Volume (K) (2025-2032) By Application

Table 80: Global Market Share (%) By Application (2032)

Table 81: Global Market Volume (K) (2025-2032) By Types

Table 82: Global Market Share (%) By Types (2032)

Table 83: Global Fully Automated Blood Grouping System Market Value (USD Million) By Region

Table 84: Global Fully Automated Blood Grouping System Market Share (%) By Region (2025-2032)

Table 85: North America Market Value (USD Million) (2025-2032) By Country

Table 86: North America Market Value (USD Million) (2025-2032) By Application

Table 87: North America Market Value (USD Million) (2025-2032) By Types

Table 88: Europe Market Value (USD Million) (2025-2032) By Country

Table 89: Europe Market Value (USD Million) (2025-2032) By Application

Table 90: Europe Market Value (USD Million) (2025-2032) By Types

Table 91: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 92: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 93: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 94: South America Market Value (USD Million) (2025-2032) By Country

Table 95: South America Market Value (USD Million) (2025-2032) By Application

Table 96: South America Market Value (USD Million) (2025-2032) By Types

Table 97: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 98: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 99: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 100: Global Fully Automated Blood Grouping System Market Volume (K) By Region

Table 101: Global Fully Automated Blood Grouping System Market Share (%) By Region (2025-2032)

Table 102: North America Market Volume (K) (2025-2032) By Country

Table 103: North America Market Volume (K) (2025-2032) By Application

Table 104: North America Market Volume (K) (2025-2032) By Types

Table 105: Europe Market Volume (K) (2025-2032) By Country

Table 106: Europe Market Volume (K) (2025-2032) By Application

Table 107: Europe Market Volume (K) (2025-2032) By Types

Table 108: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 109: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 110: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 111: South America Market Volume (K) (2025-2032) By Country

Table 112: South America Market Volume (K) (2025-2032) By Application

Table 113: South America Market Volume (K) (2025-2032) By Types

Table 114: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 115: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 116: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 117: Research Programs/Design For This Report

Table 118: Key Data Information From Secondary Sources

Table 119: Key Data Information From Primary Sources

FAQs

1. What is the current Fully Automated Blood Grouping System market size?

The Fully Automated Blood Grouping System market size was estimated at roughly USD 1.1 billion in 2023, reflecting strong demand from hospitals and blood banks seeking higher throughput and reduced manual error in blood typing processes worldwide.

2. What is the projected growth rate and forecast period?

Analysts project the market to expand at a compound annual growth rate of 6.2 % between 2024 and 2032, reaching an estimated USD 1.9 billion by the end of the forecast horizon, driven by automation adoption and regulatory incentives.

3. What are the primary drivers fueling market expansion?

Key drivers include rising blood transfusion volumes, increasing prevalence of chronic diseases, pressure to minimize human error, and hospital initiatives to modernize laboratory workflows; together they boost demand for fully automated systems that deliver rapid, accurate blood grouping.

4. What challenges could hinder market growth?

Barriers consist of high upfront capital costs, integration complexity with legacy laboratory information systems, limited skilled personnel for maintenance, and stringent validation requirements that can extend deployment timelines, especially in low‑resource healthcare settings and under regulatory scrutiny.

5. Which regions lead the market and why?

North America remains the largest region, driven by extensive hospital networks and early adoption of advanced diagnostics; Europe follows with strong public health programs; the Asia‑Pacific region shows the fastest growth, propelled by expanding blood banks and government investment in automation.

6. Who are the top companies competing in this space?

Leading players include Siemens Healthineers, Abbott Laboratories, Bio‑Rad Laboratories, Ortho Clinical Diagnostics, and Roche Diagnostics, each offering integrated platforms that combine blood grouping with broader immunohematology testing, while also investing in R&D to enhance throughput and data connectivity.

7. What future opportunities are emerging for the market?

Emerging opportunities involve AI‑driven result interpretation, cloud‑based data analytics for population‑level blood management, and modular designs that allow scaling from small clinics to large transfusion centers, positioning the market for sustained expansion beyond traditional laboratory environments.

8. How is technology reshaping the Fully Automated Blood Grouping System market?

Advances in microfluidics, machine‑learning algorithms, and real‑time connectivity enable faster, more precise antigen detection and seamless integration with electronic health records, reducing turnaround time and supporting personalized transfusion strategies, thereby redefining competitive benchmarks for industry.

9. What is the regulatory landscape affecting market adoption?

Regulators such as the FDA, EMA, and regional health authorities mandate strict validation, quality‑management systems, and post‑market surveillance for fully automated blood grouping devices; compliance with ISO 15189 and IEC 60601 standards is essential for market entry and sustained distribution.

10. What is the long‑term future outlook for the Fully Automated Blood Grouping System market?

The future outlook for the Fully Automated Blood Grouping System market is positive, with anticipated CAGR above 6 % through 2035, driven by digital health convergence, expanding transfusion services in emerging economies, and continuous innovation that lowers costs while enhancing diagnostic accuracy.

Contact for Full Report

Loading report content...

Fully Automated Blood Grouping System Size, Share & Forecast Analysis 2025–2033

Market Snapshot

Fully Automated Blood Grouping System Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Fully Automated Blood Grouping System Segmentation

Fully Automated Blood Grouping System Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Fully Automated Blood Grouping System market size?

2. What is the projected growth rate and forecast period?

3. What are the primary drivers fueling market expansion?

4. What challenges could hinder market growth?

5. Which regions lead the market and why?

6. Who are the top companies competing in this space?

7. What future opportunities are emerging for the market?

8. How is technology reshaping the Fully Automated Blood Grouping System market?

9. What is the regulatory landscape affecting market adoption?

10. What is the long‑term future outlook for the Fully Automated Blood Grouping System market?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Fully Automated Blood Grouping System Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Fully Automated Blood Grouping System Segmentation

Fully Automated Blood Grouping System Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Fully Automated Blood Grouping System market size?

2. What is the projected growth rate and forecast period?

3. What are the primary drivers fueling market expansion?

4. What challenges could hinder market growth?

5. Which regions lead the market and why?

6. Who are the top companies competing in this space?

7. What future opportunities are emerging for the market?

8. How is technology reshaping the Fully Automated Blood Grouping System market?

9. What is the regulatory landscape affecting market adoption?

10. What is the long‑term future outlook for the Fully Automated Blood Grouping System market?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation